Please login to the form below

Not currently logged in
Email:
Password:

EY appoints global life sciences industry leader

Pamela Spence brings nearly 20 years of life sciences expertise to the role

EY Pamela SpenceEY has appointed Pamela Spence as industry leader for its global life sciences practice.

Spence has nearly 20 years of experience working with clients across the life sciences and healthcare sectors, most recently having served as global lead partner for a number of EY's international life sciences clients.

She first joined EY in 1998 and has since held increasingly senior leadership positions in its transaction advisory services within the health and technology sectors.

In her new role, Spence will continue to serve on the EU global accounts committee, which oversees the strategic direction of all the company's industry sectors.

She said: “Around the world, companies in the sector are looking to transform and innovate their strategies as they adapt to various health care reforms and the evolving industry landscape.

“New solutions will be required to meet the global challenges of sustainability of healthcare systems, aging populations, chronic disease and increasing cost pressures.

“I look forward to working with our team of dedicated professionals to help our clients respond to these and other challenges.” 

29th July 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics